Human cytomegalovirus virion-associated mRNA as a marker of productive infection in immunocompromised patients.
Federica Giardina1, Stefania Paolucci2,*, Dalila Mele2, Omar Mura2, Marina Ramus2, José Camilla Sammartino1, Piera d’Angelo2, Antonino Maria Guglielmo Pitrolo2, Giulia Campanini2, Eleonora Francesca Pattonieri3, Teresa Rampino3,4, Marilena Gregorini3,4, Francesca Compagno5, Domenica Federica Briganti6, Elena Seminari7, Nicola Polverelli8, Irene Cassaniti1,2, Daniele Lilleri1, Fausto Baldanti1,2.
1Department of Clinical Surgical Diagnostic and Pediatric Sciences, Università degli Studi di Pavia, Italy
2Microbiology and Virology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
3Nephrology, Dialysis and Transplantation, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
4Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy
5Pediatric Oncohematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
6Transplant Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
7Infectious Diseases I, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
8Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
*Corresponding author:
Stefania Paolucci; email: s.paolucci@smatteo.pv.it
Running head: Virion-associated CMV mRNA in plasma